These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 19929599)
21. [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations]. Bühling KJ; Mönnich J; Henrich W; Brauer M; Heinze T; Siebert G; Dudenhausen JW Z Geburtshilfe Neonatol; 2004 Dec; 208(6):226-31. PubMed ID: 15647986 [TBL] [Abstract][Full Text] [Related]
22. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. Kang ES; Yun YS; Park SW; Kim HJ; Ahn CW; Song YD; Cha BS; Lim SK; Kim KR; Lee HC Metabolism; 2005 Feb; 54(2):206-11. PubMed ID: 15690315 [TBL] [Abstract][Full Text] [Related]
23. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Di Cianni G; Miccoli R; Volpe L; Lencioni C; Ghio A; Giovannitti MG; Cuccuru I; Pellegrini G; Chatzianagnostou K; Boldrini A; Del Prato S Diabet Med; 2005 Jan; 22(1):21-5. PubMed ID: 15606686 [TBL] [Abstract][Full Text] [Related]
24. Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester. Leipold H; Worda C; Gruber CJ; Prikoszovich T; Wagner O; Kautzky-Willer A Eur J Clin Invest; 2005 Dec; 35(12):752-7. PubMed ID: 16313251 [TBL] [Abstract][Full Text] [Related]
25. Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy. Fallucca F; Dalfrà MG; Sciullo E; Masin M; Buongiorno AM; Napoli A; Fedele D; Lapolla A Metabolism; 2006 Nov; 55(11):1451-6. PubMed ID: 17046546 [TBL] [Abstract][Full Text] [Related]
26. First-trimester nuchal translucency screening in pregnant women who subsequently developed gestational diabetes. Leipold H; Worda C; Ozbal A; Husslein P; Krampl E J Soc Gynecol Investig; 2005 Oct; 12(7):529-32. PubMed ID: 16046155 [TBL] [Abstract][Full Text] [Related]
27. Using the 100-g oral glucose tolerance test to predict fetal and maternal outcomes in women with gestational diabetes mellitus. Lin CH; Wen SF; Wu YH; Huang MJ Chang Gung Med J; 2009; 32(3):283-9. PubMed ID: 19527607 [TBL] [Abstract][Full Text] [Related]
28. Determination of insulin resistance using the homeostatic model assessment (HOMA) and its relation with the risk of developing pregnancy-induced hypertension. Sierra-Laguado J; García RG; Celedón J; Arenas-Mantilla M; Pradilla LP; Camacho PA; López-Jaramillo P Am J Hypertens; 2007 Apr; 20(4):437-42. PubMed ID: 17386353 [TBL] [Abstract][Full Text] [Related]
29. [Correlation between the expression of gastrocolic omentum visfatin mRNA and gestational diabetes mellitus]. Liang Y; Xu XM; Wang HS; Wang PW Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):824-7. PubMed ID: 19087564 [TBL] [Abstract][Full Text] [Related]
30. Maternal serum adiponectin concentration in gestational diabetes. Soheilykhah S; Mohammadi M; Mojibian M; Rahimi-Saghand S; Rashidi M; Hadinedoushan H; Afkhami-Ardekani M Gynecol Endocrinol; 2009 Sep; 25(9):593-6. PubMed ID: 19626510 [TBL] [Abstract][Full Text] [Related]
31. Recurrence of gestational diabetes mellitus: identification of risk factors. Spong CY; Guillermo L; Kuboshige J; Cabalum T Am J Perinatol; 1998 Jan; 15(1):29-33. PubMed ID: 9475684 [TBL] [Abstract][Full Text] [Related]
32. Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Damm P Dan Med Bull; 1998 Nov; 45(5):495-509. PubMed ID: 9850811 [TBL] [Abstract][Full Text] [Related]
34. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Tsai PJ; Yu CH; Hsu SP; Lee YH; Huang IT; Ho SC; Chu CH Nutrition; 2005; 21(11-12):1095-9. PubMed ID: 16308131 [TBL] [Abstract][Full Text] [Related]
35. Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: evaluation in a large cohort of subjects assessed with the 1999 World Health Organization criteria for the classification of diabetes. Moro E; Gallina P; Pais M; Cazzolato G; Alessandrini P; Bittolo-Bon G Metabolism; 2003 May; 52(5):616-9. PubMed ID: 12759893 [TBL] [Abstract][Full Text] [Related]
36. The impact of family history of type 2 diabetes on pancreatic beta-cell function. Wang ZH; Zhang SH; Gong LL; Ren W; Li R; Zheng RZ; Zhang YF; Wang MR; Li QF Diabetes Res Clin Pract; 2009 Oct; 86(1):61-6. PubMed ID: 19674808 [TBL] [Abstract][Full Text] [Related]
37. Insulin resistance in chronic hepatitis B virus infection. Kumar M; Choudhury A; Manglik N; Hissar S; Rastogi A; Sakhuja P; Sarin SK Am J Gastroenterol; 2009 Jan; 104(1):76-82. PubMed ID: 19098853 [TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Kinalski M; Telejko B; Kuźmicki M; Kretowski A; Kinalska I Horm Metab Res; 2005 Jul; 37(7):450-4. PubMed ID: 16034719 [TBL] [Abstract][Full Text] [Related]
39. Characteristics of patients with abnormal glucose challenge test and normal oral glucose tolerance test results: comparison with normal and gestational diabetic patients. Dudhbhai M; Lim L; Bombard A; Juliard K; Meenakshi B; Trachelenberg Y; Weiner Z Am J Obstet Gynecol; 2006 May; 194(5):e42-5. PubMed ID: 16647897 [TBL] [Abstract][Full Text] [Related]
40. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein. Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]